PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas (Review)

Xiang,Li; Kong,Beihua

doi:10.3892/ol.2013.1121

PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas (Review)

Authors:
- Li Xiang
- Beihua Kong
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan 250012, P.R. China
Published online on: January 10, 2013 https://doi.org/10.3892/ol.2013.1121
Pages: 735-738

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Paired‑box gene 8 (PAX8) encodes a transcription factor associated with important roles in embryogenesis and disease, and is a member of the PAX gene family. PAX8 has been demonstrated to be crucial in determining cell fate during the development of the thyroid, kidney, brain, eyes and Müllerian system and regulates expression of the Wilms' tumor suppressor gene (WT1). Several previous studies have reported that PAX8 is expressed at high levels in specific types of tumor, including thyroid and renal carcinomas and pancreatic neuroendocrine tumors. In addition, PAX8 has been reported to be useful for the detection and differential diagnosis of ovarian carcinoma. The consistency of PAX8 staining in epithelial ovarian carcinomas (EOCs) and the fallopian tube has provided morphological evidence that EOC may originate from the fallopian tube. The molecular mechanism of PAX8 in the carcinogenesis of these tumors remains unclear and requires further studies.

View Figures

View References

1	Muratovska A, Zhou C, He S, Goodyer P and Eccles MR: Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene. 22:7989–7997. 2003. View Article : Google Scholar : PubMed/NCBI
2	Siehl JM, Thiel E, Heufelder K, et al: Possible regulation of Wilms’ tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Br J Haematol. 123:235–242. 2003.
3	Nonaka D, Chiriboga L and Soslow RA: Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 32:1566–1571. 2008. View Article : Google Scholar : PubMed/NCBI
4	Poleev A, Wendler F, Fickenscher H, et al: Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms’ tumors. Eur J Biochem. 228:899–911. 1995.PubMed/NCBI
5	Mittag J, Winterhager E, Bauer K and Grummer R: Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology. 148:719–725. 2007. View Article : Google Scholar : PubMed/NCBI
6	Macchia PE, Lapi P, Krude H, et al: PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet. 19:83–86. 1998. View Article : Google Scholar : PubMed/NCBI
7	Dehbi M and Pelletier J: PAX8-mediated activation of the wt1 tumor suppressor gene. Embo J. 15:4297–4306. 1996.PubMed/NCBI
8	Haynes CM, Sangoi AR and Pai RK: PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens. Cancer Cytopathol. 119:193–201. 2011. View Article : Google Scholar
9	Knoepp SM, Kunju LP and Roh MH: Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Diagn Cytopathol. 40:667–672. 2012. View Article : Google Scholar : PubMed/NCBI
10	Marques AR, Espadinha C, Catarino AL, et al: Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab. 87:3947–3952. 2002.PubMed/NCBI
11	Nikiforov YE: Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med. 135:569–577. 2011.PubMed/NCBI
12	Tong GX, Devaraj K, Hamele-Bena D, et al: PAX8: A marker for carcinoma of Müllerian origin in serous effusions. Diagn Cytopathol. 39:562–566. 2011.
13	Nikiforova MN, Lynch RA, Biddinger PW, et al: RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 88:2318–2326. 2003. View Article : Google Scholar
14	Nonaka D, Tang Y, Chiriboga L, Rivera M and Ghossein R: Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol. 21:192–200. 2008.PubMed/NCBI
15	Tacha D, Zhou D and Cheng L: Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol. 19:293–299. 2011. View Article : Google Scholar : PubMed/NCBI
16	Kroll TG, Sarraf P, Pecciarini L, et al: PAX8-PPARgamma 1 fusion in oncogene human thyroid carcinoma. Science. 289:1357–1360. 2000. View Article : Google Scholar : PubMed/NCBI
17	Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG and Nikiforov YE: PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol. 26:1016–1023. 2002. View Article : Google Scholar : PubMed/NCBI
18	Cazzaniga G, Daniotti M, Tosi S, et al: The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. Cancer Res. 61:4666–4670. 2001.PubMed/NCBI
19	Ozcan A, Shen SS, Hamilton C, et al: PAX 8 expression in non-neoplastic tissues, primary tumors and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 24:751–764. 2011. View Article : Google Scholar : PubMed/NCBI
20	Albadine R, Schultz L, Illei P, et al: PAX8 (+)/p63 (−) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol. 34:965–969. 2010.
21	Long KB, Srivastava A, Hirsch MS and Hornick JL: PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Am J Surg Pathol. 34:723–729. 2010.PubMed/NCBI
22	Sangoi AR, Ohgami RS and Pai RK, Beck AH, McKenney JK and Pai RK: PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma. Mod Pathol. 24:412–424. 2011. View Article : Google Scholar
23	Jemal A, Center MM, DeSantis C and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010. View Article : Google Scholar : PubMed/NCBI
24	Nagele F, Petru E, Medl M, Kainz C, Graf AH and Sevelda P: Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol. 86:259–264. 1995. View Article : Google Scholar : PubMed/NCBI
25	Eltabbakh GH, Yadav PR and Morgan A: Clinical picture of women with early stage ovarian cancer. Gynecol Oncol. 75:476–479. 1999. View Article : Google Scholar : PubMed/NCBI
26	Schaner ME, Ross DT, Ciaravino G, et al: Gene expression patterns in ovarian carcinomas. Mol Biol Cell. 14:4376–4386. 2003. View Article : Google Scholar : PubMed/NCBI
27	Bowen NJ, Logani S, Dickerson EB, et al: Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 104:331–337. 2007. View Article : Google Scholar : PubMed/NCBI
28	Laury AR, Hornick JL, Perets R, et al: PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 34:627–635. 2010.PubMed/NCBI
29	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Handbook. 7th edition. Springer; New York, NY: 2010
30	Shivakumarswamy U, Arakeri SU, Karigowdar MH and Yelikar B: Diagnostic utility of the cell block method versus the conventional smear study in pleural fluid cytology. J Cytol. 29:11–15. 2012. View Article : Google Scholar : PubMed/NCBI
31	Bárcena C and Oliva E: WT1 expression in the female genital tract. Adv Anat Pathol. 18:454–465. 2011.
32	McKnight R, Cohen C and Siddiqui MT: Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma. Cancer Cytopathol. 118:298–302. 2010. View Article : Google Scholar : PubMed/NCBI
33	Xiang L, Zheng W and Kong B: Detection of PAX8 and p53 is beneficial in recognizing metastatic carcinomas in pelvic washings, especially in cases with suspicious cytology. Gynecol Oncol. 127:595–600. 2012. View Article : Google Scholar : PubMed/NCBI
34	Landen CN, Birrer MJ and Sood AK: Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol. 26:995–1005. 2008. View Article : Google Scholar : PubMed/NCBI
35	Auersperg N, Wong AST, Choi KC, Kang SK and Leung PCK: Ovarian surface epithelium: biology, endocrinology and pathology. Endocr Rev. 22:255–288. 2001.PubMed/NCBI
36	Medeiros F, Muto MG, Lee Y, et al: The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 30:230–236. 2006. View Article : Google Scholar : PubMed/NCBI
37	Callahan MJ, Crum CP, Medeiros F, et al: Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 25:3985–3990. 2007. View Article : Google Scholar : PubMed/NCBI
38	Carcangiu ML, Radice P, Manoukian S, et al: Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers. Int J Gynecol Pathol. 23:35–40. 2004. View Article : Google Scholar
39	Finch A, Shaw P, Rosen B, Murphy J, Narod SA and Colgan TJ: Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 100:58–64. 2006. View Article : Google Scholar : PubMed/NCBI
40	Li J, Abushahin N, Pang S, et al: Tubal origin of ‘ovarian’ low-grade serous carcinoma. Mod Pathol. 24:1488–1499. 2011.
41	Marquez RT, Baggerly KA, Patterson AP, et al: Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium and colon. Clin Cancer Res. 11:6116–6126. 2005. View Article : Google Scholar : PubMed/NCBI